Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LUDA KAMENETSKY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1447235502
CMS profile
247037
Location
HOUSTON, TX

General Payments · PY2018–2024

$5,495.95

  • Reported across 328 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$658.63

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $658.63 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $961.67 56
PY2019 $856.24 54
PY2020 $649.01 38
PY2021 $914.01 57
PY2022 $782.56 45
PY2023 $673.83 40
PY2024 $658.63 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $23.40 10/10/2024 Food and Beverage Undisputed 01/23/2026 1125068891 CMS
Amgen Inc. $14.02 01/12/2024 Food and Beverage Undisputed 01/23/2026 1111613459 CMS
Amgen Inc. $17.81 06/14/2024 Food and Beverage Undisputed 01/23/2026 1111613461 CMS
Amgen Inc. $13.79 06/26/2024 Food and Beverage Undisputed 01/23/2026 1111613465 CMS
Amgen Inc. $14.89 09/20/2024 Food and Beverage Undisputed 01/23/2026 1111613463 CMS
AstraZeneca Pharmaceuticals LP $20.21 02/16/2024 Food and Beverage Undisputed 01/23/2026 1105800845 CMS
AstraZeneca Pharmaceuticals LP $15.29 05/09/2024 Food and Beverage Undisputed 01/23/2026 1104674179 CMS
AstraZeneca Pharmaceuticals LP $14.56 09/13/2024 Food and Beverage Undisputed 01/23/2026 1104323352 CMS
AstraZeneca Pharmaceuticals LP $22.53 11/14/2024 Food and Beverage Undisputed 01/23/2026 1105856984 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.82 04/05/2024 Food and Beverage Undisputed 01/23/2026 1086219399 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.11 08/20/2024 Food and Beverage Undisputed 01/23/2026 1086144295 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.83 10/25/2024 Food and Beverage Undisputed 01/23/2026 1086127044 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.87 01/26/2024 Food and Beverage Undisputed 01/23/2026 1118011519 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.24 02/22/2024 Food and Beverage Undisputed 01/23/2026 1118011515 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.92 05/16/2024 Food and Beverage Undisputed 01/23/2026 1118011513 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.42 06/13/2024 Food and Beverage Undisputed 01/23/2026 1118011521 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.24 08/20/2024 Food and Beverage Undisputed 01/23/2026 1118011517 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.97 10/31/2024 Food and Beverage Undisputed 01/23/2026 1118011523 CMS
Currax Pharmaceuticals LLC $15.87 10/07/2024 Food and Beverage Undisputed 01/23/2026 1089512932 CMS
GlaxoSmithKline, LLC. $24.10 03/09/2024 Food and Beverage Undisputed 01/23/2026 1116466682 CMS
GlaxoSmithKline, LLC. $15.92 06/21/2024 Food and Beverage Undisputed 01/23/2026 1116525188 CMS
Lilly USA, LLC $29.37 02/20/2024 Food and Beverage Undisputed 01/23/2026 1135135118 CMS
Lilly USA, LLC $14.94 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135149160 CMS
Lilly USA, LLC $26.12 07/24/2024 Food and Beverage Undisputed 01/23/2026 1135135120 CMS
Lilly USA, LLC $16.24 12/05/2024 Food and Beverage Undisputed 01/23/2026 1135135116 CMS
Novo Nordisk Inc $19.61 01/30/2024 Food and Beverage Undisputed 01/23/2026 1096926846 CMS
Novo Nordisk Inc $17.42 03/07/2024 Food and Beverage Undisputed 01/23/2026 1097497530 CMS
Novo Nordisk Inc $14.36 04/04/2024 Food and Beverage Undisputed 01/23/2026 1097602313 CMS
Novo Nordisk Inc $13.11 04/19/2024 Food and Beverage Undisputed 01/23/2026 1096693751 CMS
Novo Nordisk Inc $1.91 05/07/2024 Food and Beverage Undisputed 01/23/2026 1097609271 CMS
Novo Nordisk Inc $12.87 05/08/2024 Food and Beverage Undisputed 01/23/2026 1096622278 CMS
Novo Nordisk Inc $15.50 06/24/2024 Food and Beverage Undisputed 01/23/2026 1097080395 CMS
Novo Nordisk Inc $11.65 07/15/2024 Food and Beverage Undisputed 01/23/2026 1097276340 CMS
Novo Nordisk Inc $22.72 08/22/2024 Food and Beverage Undisputed 01/23/2026 1096934209 CMS
Novo Nordisk Inc $14.74 09/11/2024 Food and Beverage Undisputed 01/23/2026 1096789110 CMS
Novo Nordisk Inc $22.38 09/25/2024 Food and Beverage Undisputed 01/23/2026 1097701636 CMS
Novo Nordisk Inc $14.48 11/05/2024 Food and Beverage Undisputed 01/23/2026 1096873979 CMS
Novo Nordisk Inc $15.40 12/03/2024 Food and Beverage Undisputed 01/23/2026 1097709751 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.